Linking market authorizations of medicines with disease burden in South Africa
Background: Sub-Saharan Africa is going through an epidemiological transition, including an impressive increase in non-communicable diseases. The introduction of medicines has not kept pace with the needs in developing countries. The objectives of this study were to (i) examine the correlation betwe...
Main Authors: | Leufkens, H.G.M (Author), Mantel-Teeuwisse, A.K (Author), Narsai, K. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Linking market authorizations of medicines with disease burden in South Africa
by: K. Narsai, et al.
Published: (2021-04-01) -
Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study
by: Anastasiia Russkikh, et al.
Published: (2021-01-01) -
Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China
by: Abela Mpobela Agnarson, et al.
Published: (2020-02-01) -
Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States
by: Connie A. Haley, et al.
Published: (2021-01-01) -
A clinical case of successful combined treatment of a patient with fibrous cavernous pulmonary tuberculosis and extensive drug resistance
by: P. N. Golubchikov, et al.
Published: (2020-07-01)